Product Information
ANAGRELIDE HCL 0.5 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.7295 per EA under NDC 62135031212. Its NADAC has been published 82 times since Mar 12, 2025.
FDA first approved this application on Apr 18, 2005.
Strength
.5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135031212
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ANAGRELIDE HYDROCHLORIDE ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA076683FDA Approved
4/18/2005
On Market Since
4/18/2005
Pharmacological Classes
Price Statistics
The NADAC for ANAGRELIDE HCL 0.5 MG CAPSULE has been published 82 times since Mar 12, 2025, and over the history we have for it it has declined 4.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7295 per EA |
|---|---|
| All-time high | $0.7604 (Mar 12, 2025) |
| All-time low | $0.7066 (Aug 20, 2025) |
| 52-week high | $0.7345 |
| 52-week low | $0.7087 |
| Median price | $0.7260 |
| Average price | $0.7257 |
| Largest weekly change | -2.1% (May 21, 2025) |
| Weeks tracked | 82 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Anagrelide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Platelet-reducing Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANAGRELIDE HCL 0.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ANAGRELIDE HCL 0.5 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.7295 per EA (NDC 62135031212), effective Sep 30, 2026.
How has the price of ANAGRELIDE HCL 0.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ANAGRELIDE HCL 0.5 MG CAPSULE has declined 4.1%. It has been tracked across 82 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for ANAGRELIDE HCL 0.5 MG CAPSULE?
Since Mar 12, 2025, the NADAC for ANAGRELIDE HCL 0.5 MG CAPSULE has ranged from a low of $0.7066 (Aug 20, 2025) to a high of $0.7604 (Mar 12, 2025), with a median of $0.7260 per EA.
Are there cheaper alternatives to ANAGRELIDE HCL 0.5 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ANAGRELIDE HCL 0.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ANAGRELIDE HCL 0.5 MG CAPSULE?
ANAGRELIDE HCL 0.5 MG CAPSULE (NDC 62135031212) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.